Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development
Heena Agarwal(Columbia University Irving Medical Center), Lale Özcan(Columbia University)
Cited by 7
Related Papers
Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol
|Circulation Research|2019|63
Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9
|Journal of Lipid Research|2024|7
Hepatic Glucagon Signaling Regulates PCSK9 and LDL-Cholesterol
|PubMed Central|2018|1